Thymic selection generates a large T cell pool recognizing a self-peptide in humans - Wikidata - awgldk - TriplyDB

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

http://www.wikidata.org/entity/Q24675080

about

Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection Far East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen A Melanoma-associated leukoderma - immunology in black and white?Structures of MART-126/27–35 Peptide/HLA-A2 Complexes Reveal a Remarkable Disconnect between Antigen Structural Homology and T Cell Recognition T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting A human memory T cell subset with stem cell-like properties Conditional immortalization of human B cells by CD40 ligation.Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.Mechanisms of malignant glioma immune resistance and sources of immunosuppression HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.Specific roles of each TCR hemichain in generating functional chain-centric TCR.Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?DNA fusion gene vaccines against cancer: from the laboratory to the clinic.Analysis of the functional WT1-specific T-cell repertoire in healthy donors reveals a discrepancy between CD4(+) and CD8(+) memory formation.Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients Reduced naïve CD8(+) T-cell priming efficacy in elderly adults.Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.Mobilizing the low-avidity T cell repertoire to kill tumors.Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced interleukin 12 synthesis.A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma.PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis Is antigen specificity the key to efficient adoptive T-cell therapy?A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.Lymphocyte homeostasis and the antitumor immune response.Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.T cell Receptor Alpha Variable 12-2 bias in the immunodominant response to Yellow fever virus.MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells.Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.

P2860

Q24673373-7371B14B-1E48-4143-915E-FEFCAC057368 Q24795912-52BB2696-CFCE-4896-A38D-B83375CC3238 Q26773071-49CBB65C-1256-4F22-844B-4FB46E93DA26 Q26850001-6152CEB1-4626-4459-B20F-6498EE757FB3 Q27647534-DF179523-643F-4E70-8DBD-F4DD68354092 Q27672418-52B2B01F-834E-4A32-9453-A11B6124266E Q28248395-459DD7D2-568C-4516-9D33-0CAA74BCE2D5 Q33316020-41741547-772D-42EA-AE93-BC2E6447C465 Q34338725-D625536F-A37E-481B-B4EC-3D71E12DD73B Q34560957-A6A28B1D-644C-46C6-B986-0D3AE1C37BD9 Q34594769-9DF227C6-4080-4970-9904-E95EF89B8758 Q34606735-EA340CE9-0B61-44F7-90D7-F54CA988F913 Q34661793-3D67FD88-F588-4763-8901-551D8E90C123 Q34707327-5352F907-73F7-4158-9F17-86BC8AECB1F3 Q35005935-BE249698-BEF9-4C32-9D88-52D363800DB7 Q35005940-C2856533-50E7-4967-951D-A1B6D37F4468 Q35005955-8A1B683A-8AF4-4F1B-B503-2D030716E7B8 Q35205495-DA7B3757-053A-4C7D-8747-BC897921783A Q35594089-578F9DFF-86E5-4191-8039-811215E5FFCD Q35826392-B59C8F06-594C-400C-8111-99E4BD53C77B Q35889240-8B5C5CBA-EF5A-4ABB-9396-803F3BEF810B Q36150417-5139C93C-F1C0-45A8-A684-D5C0985CA8D3 Q36299933-83920668-6009-4A6D-BE85-3987D9F0C034 Q36475259-54A0E532-4527-4F32-84FA-7BEBBB49824C Q36499634-E1837FFE-55FC-4413-AF46-066B304E2B92 Q36891310-67135462-D492-4A44-A0F7-0291B9DBA836 Q37098840-4F55C1AA-48AD-4F37-998F-80F91800D2C3 Q37249766-7921CD95-E287-47B4-8E45-4FAF37F97C60 Q37318142-3D3BD28A-5BEA-4278-9257-703450225243 Q37570169-C9E9F31C-5192-4D1A-A2C3-47B4265E5A83 Q37593413-3C18ED17-106A-4927-9450-DB03C9B56896 Q37861214-1C54327D-8E79-4B73-B1A5-55844219FBF9 Q40351656-86D31761-8DD6-400F-AA53-C30DD057A8A6 Q40393609-D58A1F35-7469-4722-B8BE-3B8C7FF8BC94 Q41306886-6DB32B8A-69DC-417F-9AC6-DE161E132914 Q41580130-830998BE-66CC-4E5D-BBE9-378D859F3092 Q41924958-150BEE03-1D96-4ED0-AA44-BA1F6F7C5957 Q41955439-4F9E89AB-E32A-46B5-80AF-398CAFE4D4F3 Q42003336-7503DDFA-4DC0-4AD8-801F-05FC09558E83 Q47221521-D73445AE-BB2E-4C6A-B33A-27934A75FF90

P2860

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

http://www.wikidata.org/entity/Q24675080

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@ast

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@en

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@nl

type

label

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@ast

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@en

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@nl

prefLabel

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@ast

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@en

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@nl

P1433

Q24675080-7EA9F298-50FE-438B-8C53-B77736C3F3A3

P1476

Q24675080-B0D56C11-5F52-4840-ABCE-CFFC718504B7

P2093

Q24675080-0C6181AD-8F49-49B1-9524-E47FA500BF56

Q24675080-156E4963-333F-4F6E-9643-F8BB2CAEF3D7

Q24675080-1A4CE671-8F1E-406D-800E-8E8F05B11DF8

Q24675080-344E20A0-F56E-4091-9BB9-11EA62F3078A

Q24675080-3BCC9324-72F1-42B8-A855-40B275E11298

Q24675080-4B3D1B65-DEAB-4497-B970-E1DD1CE46340

Q24675080-5C371C4E-A16D-46AB-85BF-9F057A22AB66

Q24675080-5EC001FA-5B42-4696-8EED-BC59E5F7F658

Q24675080-65B79694-F49B-47E6-84D9-2698689FF4CF

Q24675080-7A152CB9-FE70-4772-8C1A-CCECEAC31F7B

P2860

Q24675080-1631C014-7D12-4D9D-AB24-7CCB0AFF52A7

Q24675080-2D1C0EFF-4481-4B3B-AD40-C3C26BDE7C7F

Q24675080-32B9F543-5075-4E54-8E3C-007D8AF3F508

Q24675080-36D7C856-54F2-4BE1-A3AD-06E6263332C0

Q24675080-47A6FBB6-780B-42B2-898A-18D4C77B7D5E

Q24675080-49FBDD10-3AEB-4092-9B55-60415381E286

Q24675080-4BB41032-84CB-41B8-965A-9845802E6EB9

Q24675080-50F50371-70A6-4BC1-85C8-5785BC567748

Q24675080-510162D9-B09B-45C0-8A52-5C4623D8DA28

Q24675080-5193418E-DDF3-43C4-8FB8-D23749E7DDB7

P304

Q24675080-DD1C1296-925B-4EFE-9D0F-A0CE4512E66E

P31

Q24675080-E0626566-8C83-4A45-9DB7-A8C57D2CAFA8

P356

Q24675080-4A0806A8-F506-4789-9A37-B4434ED11AAE

P407

Q24675080-943E2802-FECD-48C1-898E-F06253AD511B

P433

Q24675080-6D0A3B91-41F2-455A-B030-48B0F0D00B81

P478

Q24675080-963ADEC9-ACAA-4066-9D9B-1F30CD8E1443

P577

Q24675080-54369A09-474F-4663-B481-67C8F6513E24

P5875

Q24675080-1E534869-338E-4FAC-B5A7-45D4544750DE

P698

Q24675080-2FD638DB-3459-4246-974F-CBAE168396EB

P932

Q24675080-2F2CB7B9-B5D1-453C-A998-D7D5CBCEA8A6

P356

P1433

Journal of Experimental Medicine

P1476

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

@en

P2093

Alfred Zippelius

http://www.w3.org/2001/XMLSchema#string

Daniel E Speiser

http://www.w3.org/2001/XMLSchema#string

Danielle Liénard

http://www.w3.org/2001/XMLSchema#string

Danila Valmori

http://www.w3.org/2001/XMLSchema#string

H Robson MacDonald

http://www.w3.org/2001/XMLSchema#string

Jean Plum

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Cerottini

http://www.w3.org/2001/XMLSchema#string

Kim Ellefsen

http://www.w3.org/2001/XMLSchema#string

Magda de Smedt

http://www.w3.org/2001/XMLSchema#string

Mikaël J Pittet

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

The thymus and central tolerance

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Phenotypic analysis of antigen-specific T lymphocytes

Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency.

Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes.

Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35).

Human naive and memory T lymphocytes differ in telomeric length and replicative potential.

Selecting and maintaining a diverse T-cell repertoire.

P304

485-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20011658

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11507919

http://www.w3.org/2001/XMLSchema#string

P698

11854361

http://www.w3.org/2001/XMLSchema#string

P932

2193620

http://www.w3.org/2001/XMLSchema#string